Personalized medicine: CCO's vision, accomplishments and future plans.
Healthc Q
; 17 Spec No: 41-3, 2015.
Article
em En
| MEDLINE
| ID: mdl-25562133
ABSTRACT
Personalized medicine is a rapidly expanding field, with the potential to improve patient care. Its benefits include increasing efficiency in cancer screening, diagnosis and treatment through early detection, targeted therapy and identifying individuals with an underlying genetic risk for cancer or adverse outcomes. Through the work of Cancer Care Ontario (CCO)'s Pathology and Laboratory Medicine Program, a number of initiatives have been undertaken to support developments in personalized medicine. In keeping with the momentum of recent accomplishments, CCO has led the formation of the Personalized Medicine Steering Committee to develop a comprehensive provincial genetics strategy for the future of cancer care.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Medicina de Precisão
/
Oncologia
Tipo de estudo:
Prognostic_studies
/
Screening_studies
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Healthc Q
Assunto da revista:
HOSPITAIS
/
SERVICOS DE SAUDE
Ano de publicação:
2015
Tipo de documento:
Article